Maharashtra Sees 43 New COVID-19 Cases, Active Count Crosses 200
K N Mishra
26/May/2025

What’s Covered Under the Article
-
Maharashtra logs 43 new COVID-19 cases on Sunday, pushing the active count above 200, with Mumbai and Pune reporting most new infections.
-
May accounts for 80% of all COVID-19 cases in the state this year, with Mumbai contributing over 82% of the total infections so far.
-
New variants NB.1.8.1 and LF.7 detected in India; JN.1 remains dominant; Centre urges public vigilance amid mild case trends.
Maharashtra has reported 43 new COVID-19 cases on Sunday, May 25, 2025, pushing the state’s active case count to 209, according to data released by the Maharashtra health department. The majority of the new infections were reported from Mumbai, which accounted for 35 cases, while Pune recorded 8 new cases. This surge reflects ongoing transmission within the state, especially concentrated in major urban centres.
COVID-19 Trends in Maharashtra Since January 2025
Since January 2025, Maharashtra has recorded a total of 300 COVID-19 cases. The monthly breakdown highlights a sharp rise in May, which alone accounts for 242 cases or 80% of the total for the year. Earlier months saw significantly fewer infections with January and February reporting just one case each, March none, and April a slight increase with 4 cases. Mumbai remains the epicentre within the state, having reported 248 infections, which is about 82.67% of Maharashtra’s total cases so far this year.
Rising COVID-19 Cases Across India
Maharashtra is not alone in witnessing a resurgence. Other states like Kerala, Tamil Nadu, Karnataka, and Delhi are also reporting an uptick in COVID-19 cases. Kerala, in particular, has emerged as the state with the highest number of new infections. The Union Health Ministry has noted this increase but reassures the public that most cases are mild and managed under home isolation protocols.
Health Ministry’s Advisory and Surveillance Measures
The Ministry of Health and Family Welfare has issued an advisory following the recent rise in COVID-19 cases across multiple states. The advisory stresses the importance of remaining vigilant without panic. It highlights the existence of a robust national surveillance system, involving the Integrated Disease Surveillance Programme (IDSP) and the Indian Council of Medical Research (ICMR)’s sentinel surveillance network. These systems continue to monitor respiratory illnesses, including COVID-19, to detect and respond to changes in transmission patterns or severity.
Emergence of New Variants in India
The Indian SARS-CoV-2 Genomics Consortium (INSACOG) has identified the presence of emerging variants contributing to the current rise in cases. Specifically, one case of the NB.1.8.1 variant and four cases of the LF.7 variant have been detected. Both LF.7 and NB.1.8 are classified by the World Health Organization (WHO) as Variants Under Monitoring (VUMs) as of May 2025. These variants are not currently listed as Variants of Concern (VOCs) or Variants of Interest (VOIs) but have been associated with recent surges in COVID-19 in parts of Asia, including China.
Within India, the most prevalent variant remains the JN.1 variant, accounting for approximately 53% of samples tested. This is followed by BA.2 (26%) and other Omicron sublineages (20%), showing the continuing dominance of Omicron-related strains.
Outlook and Precautions
While Maharashtra and other states see a rise in cases, the current data suggests the severity and transmissibility have not escalated dramatically. The majority of infections continue to be mild, requiring only home isolation and minimal medical intervention. Public health authorities recommend continued adherence to COVID-appropriate behaviour, including mask-wearing in crowded places, hand hygiene, and vaccination updates where eligible.
The government’s surveillance and genomic sequencing efforts will be critical in early detection and containment of any potentially dangerous variants, ensuring that public health responses remain swift and effective.
Summary
In summary, Maharashtra has reported 43 new COVID-19 cases, with active infections now at 209, mostly from Mumbai and Pune. The state has seen a sharp rise in cases since May 2025, aligning with a broader increase across several Indian states. Although new variants LF.7 and NB.1.8.1 have been detected, most infections remain mild. The Union Health Ministry urges citizens to stay vigilant while highlighting the robust surveillance infrastructure monitoring the situation nationwide.
The Upcoming IPOs in this week and coming weeks are 3B Films, N R Vandana Tex Industries, Scoda Tubes,Neptune Petrochemicals, Astonea Labs, Nikita Papers, Prostarm Info Systems, Victory Electric Vehicles International, Blue Water Logistics, Wagons Learning..
The Current active IPO are Aegis Vopak Terminals, Schloss Bangalore, Unified Data - Tech Solutions.
Start your Stock Market Journey and Apply in IPO by Opening Free Demat Account in Choice Broking FinX.
Join our Trading with CA Abhay Telegram Channel for regular Stock Market Trading and Investment Calls by CA Abhay Varn - SEBI Registered Research Analyst.
Related News
Disclaimer
The information provided on this website is for educational and informational purposes only and should not be considered as financial advice, investment advice, or trading recommendations.
Trading in stocks, forex, commodities, cryptocurrencies, or any other financial instruments involves high risk and may not be suitable for all investors. Prices can fluctuate rapidly, and there is a possibility of losing part or all of your invested capital.
We do not guarantee any profits, returns, or outcomes from the use of our website, services, or tools. Past performance is not indicative of future results.You are solely responsible for your investment and trading decisions. Before making any financial commitment, it is strongly recommended to consult with a qualified financial advisor or do your own research.
By accessing or using this website, you acknowledge that you have read, understood, and agree to this disclaimer. The website owners, partners, or affiliates shall not be held liable for any direct or indirect loss or damage arising from the use of information, tools, or services provided here.